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A basis for interest in the benzimidazole ring system as a nucleus from which to develop potential chemotherapeutic agents was established in the I95Os when it was found that 5,6-dimethyl-I -(a-D-ribofiranosyljbenzimidazole (I) was an integral part ofthe structure of vitamin 6,~ As a result of these interests and extensive studies, one health related arena that has benefited greatly has been the treatment ofparasitic diseases. The discovery of thiabendazole in I96 I further spurred chemists around the world to design and synthesize several thousand benzimidazoles for screening for anthelmirltic activity but less than twenty ofthem have reached commercial use. Much ofthis work has been done by pharmaceutical companies and is only reported in the patent literature. In this paper, Leroy Townsend and Dean Wise review the development ofsome cfthe synthetic methods that have been critical to the preparation of the benzimidazoles ofanthelmintic importance. On/y a few ,nolecules that demonstrate the processes are discussed here, but numerous reviews of the synthesis andchemistry ofother benzimidazoles are available'".
Box I. Tautomerism and isomerism
The systematic numbering of the benzimidazole ring system is shown in structure 1. Although benzimidazole is depicted in I as ecule. Tautomerism occurs through either an intermolecular process involving two or more benzimidazole molecules or through interactions witlh a protic solvent such as water. It renders the 5-and 6-positions, and any group at that position in the ring system, chemically equivalent. In N-substituted benzimidazoles, tautomerism is no longer possible and two distinct non-equivalent molecules or isomers may be isolated and characterized. For example, the two dimethylated benzimidazoles shown are an isomeric pair of non-equivalent molecules, while the mono-methylated molecules are tautomers and equivalent.
Benzimidazole, as the name implies, is a bicyclic ring system in which benzene has been fused to the 4-and 5-position of the heterocycle (imidazole; Box I). Benzimidazole compounds in general, and benzimidazole carbamates in particular, are crystalline materials, with fairly high melting points and are relatively insoluble in water. Compounds that are unsubstituted on either of the imidazole nitrogen atoms possess both acidic and basic characteristics.
Modifications of the benzimidazole ring system that have been made during the search for anthelmintic activity are summarized in Box 2. Combinations of the modifications at positions 2-and 5-of the molecule has provided the most active drugs. The synthetic pathways to the various benzimidazoles usually proceeds through two steps, first the construction of a benzene ring containing the desired substituents and a I ,2-diamine grouping, followed by the ring closure of the I ,2-diaminobenzene (o-phenylenediamine) derivative to construct the imidazole ring. In many cases, this ring closure is the RE 1;; -3:
FR o -phenylenediamine R, R' = ring substitution final step in the synthesis of the desired benzimidazole. However, in other instances this ring closure is followed by extensive derivatization of the ring system or of the existing exocyclic substituents (Box 3).
The discovery4 in I96 I that 2-(4'-thiazolyl)benzimidazole (thiabendazole) possessed a very potent broad spectrum of activity against gastrointestinal parasites was the breakthrough that opened up a new era in the treatment of parasitic diseases. In the initial studies, a group of researchers at Merck prepared thiabendazole by a condensation of o-phenylenediamine with thiazole-4-carboxamide in the presence of the dehydrating agent, polyphosphoric acid. This reaction was found to be quite and a base to form benzimidazoles was devised by the Merck group5, and this discovery made it economically practical to market the 2-phenyl derivative and thiabendazole. In this procedure it is unnecessary to prepare the o-phenylenediamine compound because aniline is used as a starting material. Thus, to prepare thiabendazole (4) aniline is reacted with 4-cyanothiazole (2) in the presence of aluminium trichloride (a Lewis acid), to give the intermediate N-arylamidine hydrochloride (3). The critical oxidative cyclization to give (4) is then carried out by treating (3) with sodium hypochlorite in the presence of a base. The latter reaction has been accomplished commercially in one step, but it may also be performed stepwise through the intermediate (5) .
ltwas later found that both thiabendazoleand 2-phenylbenz imidazole suffer from an enzymatic hydroxylation at the S-position to give (a), which inactivates the drug and therefore Since hydroxylation was occurring at the 5-position, analogs of thiabendazole with different groups at this position were developed. As a potential candidate, 5-aminothiabendazole (9) was prepared by a condensation of 4-nitrophenylenediamine (7) with (2) to furnish 5-nitrothiabendazole (8) . The nitro group of compound (8) was then reduced to furnish 5-aminothiabendazole (9) . Compound (9) inactivation. These studies led to an abundance of potential functional portion of (9) with isopropyl chloroformate proanthelmintic benzimidazoles, and many methods of prepduced the 5-isoproxycarbonylamino derivative (I 0), which aration.
was marketed under the name cambendazole'. Later, Table I .
To prepare mebendazole, flubendazole, ciclobendazole, and a variety of benzimidazoles containing a group attached to the 5-position of the benzimidazole by a carbonyl (C=O) linkage, a general reaction scheme was developed by researchers at Janssen (see Box 3). In this synthetic sequence, the initial step is to append to ring A, the group which becomes the 5-carbonyl linked substituent. This is accomplished using a classical Friedel-Craft acylation with either an aromatic or aliphatic acid chloride and methoxy-or chlorobenzene to give (I 6) . Compound (I 6) is then converted to (I 7) by nitration at the site adjacent to the methoxyl-or chloro-group. Alternatively, the 3-nitro-4-chloro derivative (I 7) could be made in one step by acylation of 3-nitro-4-chlorobenzoyl chloride. Owing to the electron donating effects of the adjacent nitro group, the 4-methoxy or chloro group is readily converted to the 3-nitro-4-aniline derivative (18). Reduction of the nitro group by a variety of methods gives (I 9) which is ring closed to the desired benzimidazole using methoxycarbonyl-Smethylisothiourea.
To prepare oxfendazole I4 the necessary diamine (24) IS prepared by a series of reactions including a nucleophilic 20 21 22 23 24 oxfendazole substrtution of the chloro moiety of 2-amino-4-chloronitrobenzene (20) with thiophenol(2 I) in the presence of potassium carbonate. This reaction affords 2-amino-4-phenylsulfurylnitrobenzene (22) . Oxidation of (22) with one equivalent of peracetic acid gives the sulfoxide (23) which is selectively hydrogenated to give (24). Oxfendazole is obtained by an annulation of the diamine system of (24) with I ,3-bis-(methoxycarbonyl)-S-methylisothiourea.
The synthetic steps required to prepare albendazole' I further illustrate how the benzene ring may be modified before ring closure to the benzimidazole system. In this five step synthesis, 4-chloro-2-nitroaniline (25) is first acetylated with acetic anhydride to give I -acetamido-4-chloro-2-nitrobenzene (26) . Treatment of (26) with potassium thiocyanate furnishes the key intermediate I -acetamido-2-nitro-4-thiocyanatobenzene (27) . Conversion of the thiocyanato group of (27) into the required n-propylthioanalog, with a simultaneous conversion of the acetamido group to the free amine, is effected by treating (27) with I -bromopropane in the presence of a base. Reduction of the nitro group of (28) provides the diamine (29) which is subsequently ring closed to albendazole.
In an alternative synthesis, mebendazole has also been reported" to be prepared in good yield from benzo-2, I ,4-thiadiazines. Both mebendazole and flubendazole have been prepared in an improved overall yield by a series of reactions shown below. In this synthesis**, the key step is a ring closure of the appropriate diamine with methoxycarbonyl isothiocyanate, in the presence of dicyclohexyl carbodiimide (DDC) in acetonitrile. The overall yields are 77% of mebendazole and 55% of flubendazole, respectively.
Poor drug absorption and lack of water solubility are problems that limit the use of most benzimidazole carbamates against intestinal parasites. In addition, recently developed resistance to the curre,It commercially available drugs by certain parasites is also cf concern, and together these problems have prompted the development of new benzimidazole carbamate types. Among these are heterocyclic isosteres, compounds which contain a heterocyclic core other than benzimidazole. Prodrugs are being developed that are appropriately substituted benzene molecules that are enzymatically converted to an active benzimidazole carbamate after absorption by the animal under treatment.
A series of 6-substituted imidazo[ I ,2-olpyridine-2-carbamates have been prepared23, and one of these (40) has shown higher activity than any known benzimidazole against X = F,H certain parasites. To synthesize (40), the picoline (34) is prepared by the addition of chlorine to 5-ethynyl-2-methylpyridine (33) and is subsequently dehydrohalogenated with a strong base to furnish the 5-trichloro substituted intermediate (35) . Four more synthetic steps (35-39) are necessary in order to convert the 2-methyl group of (35) to the 2-amino derivative (39). Ring cyclization of (39) accomplished by treatment of the 5-methylisothiourea derivative (45) with taurine. It should be noted that netobimin as a salt is freely soluble in water and, as such, has major advantages over the benzimidazoles per se. This is an area of research that has great promise.
We have attempted to show a few examples of benzimidazole syntheses that have shown great value to humankind. Does the synthesis of new benzimidazoles still have merit, and is research in this area still going on? The answer is yes. Resistance to the now commercially available benzimidazoles has developed and poor oral absorption remain problems which have yet to be solved.
